Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study

Concerns over unacceptable high mortality in patients with rectal cancer undergoing surgery or systemic therapy who contract COVID-19 have led to widespread adoption of alternative treatment strategies.The ReCaP study aimed to study these variations and associated outcomes.

Detalles Bibliográficos
Autores principales: Clifford, R E, Harji, D, Poynter, L, Jackson, R, Adams, R, Fearnhead, N S, Vimalachandran, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Rapid Research Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136009/
https://www.ncbi.nlm.nih.gov/pubmed/33961013
http://dx.doi.org/10.1093/bjs/znab129
Descripción
Sumario:Concerns over unacceptable high mortality in patients with rectal cancer undergoing surgery or systemic therapy who contract COVID-19 have led to widespread adoption of alternative treatment strategies.The ReCaP study aimed to study these variations and associated outcomes.

Ejemplares similares